Management tracks: PhRMA, Amgen, Apellis

Sanofi (NASDAQ:SNY; Euronext:SAN) CEO Olivier Brandicourt became chairman of PhRMA. Brandicourt was chairman-elect and succeeds Robert Bradway, who is chairman and CEO of Amgen Inc. (NASDAQ:AMGN). PhRMA named Giovanni Caforio chairman-elect. Caforio is chairman and CEO of Bristol-Myers Squibb Co. (NYSE:BMY).

Amgen has hired FDA’s Leah Christl as executive director, global regulatory and R&D policy, effective March 11, the company told BioCentury. CDER announced Friday that Christl will step down as director of CDER's Therapeutic Biologics and Biosimilars Staff Center on Feb. 22 (see "CDER Biosimilars Director Christl to Leave FDA")...